Lithium Drug Interactions: Complete FDA-Based Guide to Serious Risks
Comprehensive guide to lithium drug interactions based on FDA data. Learn contraindicated combinations, major risks, and safety steps.
A 62-year-old woman with diabetic neuropathy was prescribed gabapentin to manage nerve pain. Three weeks later, her physician added oxycodone for breakthrough pain from a herniated disc. Within 48 hours, her daughter found her unresponsive, breathing shallowly, confused. A call to 911revealed dangerous respiratory depression. The ER physician immediately noted the drug combination in her chart and discontinued the oxycodone. She recovered after supportive care. This scenario plays out far too often — and it's entirely preventable.
Gabapentin, a medication that works by dampening nerve signals in the brain and spinal cord, is one of the most widely prescribed medications in the United States. It treats nerve pain, seizures, and hot flashes. But when combined with certain other drugs — particularly opioid painkillers and other central nervous system (CNS) depressants — it can trigger life-threatening complications including respiratory depression, profound sedation, and death.
This guide walks you through every major gabapentin interaction documented in FDA drug labeling, explains the mechanism behind each risk, and provides actionable guidance for patients and caregivers.
Gabapentin is a gabapentinoid — a class of medications that modulate calcium channels in nerve tissue. The FDA approves gabapentin for three main indications:
Because gabapentin is generally well-tolerated when used alone, it's often added to existing medication regimens without adequate scrutiny of interaction risk. This complacency is dangerous.
The FDA classifies two combinations as contraindicated — meaning they should be avoided entirely except in rare cases where no alternatives exist:
According to FDA drug labeling, combining gabapentin with oxycodone-containing products creates a contraindicated interaction due to additive CNS depression. Both drugs slow activity in the central nervous system. When combined, they amplify each other's effects, creating a compounding risk of:
The FDA's warning is unambiguous: this combination should be reserved only for patients where no safer alternatives exist — and even then, it requires close medical supervision. Many death reports in the FDA's Adverse Event Reporting System (FAERS) involve this exact pairing.
The FDA identifies eight additional major interactions between gabapentin and opioid painkillers and other CNS depressants. While not explicitly contraindicated, these combinations carry serious risk and demand careful medical oversight.
Gabapentin combined with any of these opioids increases the risk of respiratory depression, sedation, and death through the same mechanism: additive CNS depression. One critical detail distinguishes the hydrocodone interaction: gabapentin actually reduces hydrocodone's bioavailability (how much of the drug reaches the bloodstream), which can mask therapeutic effects. Patients may then receive higher doses, worsening the interaction risk.
FDA labeling recommends observing patients for signs of CNS depression including dizziness, difficulty concentrating, and impaired coordination.
Buprenorphine, an opioid used for pain and opioid use disorder, interacts with gabapentin to increase respiratory depression, sedation, coma, and death risk. This interaction is especially dangerous in patients on buprenorphine maintenance therapy for addiction recovery, where additional sedation can mask warning signs and lead to overdose.
Methadone, used to treat opioid addiction and severe pain, poses a major interaction risk with gabapentin. Methadone has a long half-life (18–55 hours), meaning it accumulates in the body over days. Combined with gabapentin's CNS depressant effects, the risk of respiratory depression and death is substantial.
Why do all these combinations carry such serious risk? The answer lies in a simple principle: additive pharmacologic effect.
Gabapentin and opioids both depress the central nervous system — they slow brain and spinal cord activity. This is how they relieve pain. But when two CNS depressants are taken together, their effects don't simply add; they can multiply. The brain's respiratory centers (which control breathing) become increasingly suppressed. Blood pressure drops. The patient becomes sedated, then confused, then unconscious. If respiratory depression worsens, breathing stops entirely.
This isn't theoretical. The FDA's FAERS database contains hundreds of reports of serious harm and death from these combinations.
Do not stop taking gabapentin or any other medication without speaking to your doctor. These interactions are serious, but they do not mean you cannot safely take gabapentin. Instead:
Every major interaction listed in this guide is documented in the FDA's approved drug labeling — the official prescribing information reviewed and approved by the agency. This isn't speculation or outdated advice. It's based on clinical trial data, post-marketing surveillance, and reports from patients and healthcare providers worldwide.
Yet many patients never see these warnings. Many prescribers may not carefully review labels when adding a new medication to an existing regimen. That's why independent verification is essential.
If you take gabapentin and any other medication, don't guess about interaction risk. Visit checkdruginteractions.com — the internet's most comprehensive drug interaction checker, powered by over 250,000 FDA drug records updated monthly. Enter all your medications and get instant, evidence-based information about interaction severity, mechanisms, and what to do next. You can check up to 20 drugs at once, with no account required. Your safety depends on knowing the facts.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Comprehensive guide to lithium drug interactions based on FDA data. Learn contraindicated combinations, major risks, and safety steps.
FDA data on carbamazepine interactions. Learn about 10 contraindicated drug combinations and how to stay safe.
Learn about amiodarone interactions with FDA data. Avoid contraindicated combinations that risk cardiac arrhythmias.